HanYang University Medical Center (HYUMC) Registry
Study Details
Study Description
Brief Summary
The HYUMC registry is a two-center, real-world registry of percutaneous coronary intervention in patients with coronary artery disease. From January 2012, PCI-treated patients from Hanyang University Seoul Hospitals and Hanyang University Guri Hospitals were enrolled in this registry.
The aim of this registry is to examine the long-term clinical outcomes and identify predictors of adverse outcomes following percutaneous coronary intervention conducted at academic hospitals.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
In the HYUMC registry, the researchers have gathered and assessed various demographic, laboratory, echocardiographic, and angiographic measurements (both on-admission and during follow-up), as well as conducted questionnaires among patients who underwent percutaneous coronary intervention. The primary focus of this registry is to examine the effects of these parameters on long-term clinical outcomes.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| patients with CAD undergoing PCI patients with CAD undergoing PCI with second generation DES |
Device: percutaneous coronary intervention
patients with CAD undergoing PCI with second generation DES
|
Outcome Measures
Primary Outcome Measures
- MACCE (major adverse cardiac and cerebrovascular event) [10-year]
the composite of all-cause death, myocardial infarction, stroke, or any revascularization
Secondary Outcome Measures
- All-cause death [10-year]
death from any cause
- Myocardial infarction, [10-year]
presence of clinical symptoms with the presence of electrocardiographic changes, or imaging evidence of new loss of viable myocardium or new regional wall motion abnormalities, in conjunction with elevated levels of cardiac biomarker above the 99th percentile upper reference limit
- Stroke [10-year]
neurological deficit resulting from acute focal damage to the central nervous system due to a vascular cause, requiring hospitalization, and confirmed by a neurologist through imaging findings
- Any revascularization [10-year]
PCI or coronary artery bypass surgery on either target or nontarget vessels
Eligibility Criteria
Criteria
Inclusion Criteria:
Consecutive patients with CAD who underwent PCI one or more drug eluting stent (DES) with from 2012 at the Division of Cardiology of Hanyang University Seoul Hospital and Hanyang University Guri Hospital, Korea.
Exclusion Criteria:
-
second or subsequent hospitalization records of patients with multiple admissions
-
patients who died during index hospitalization
-
patients who treated with first-generation drug eluting stent
-
patients with an outpatient follow-up record of less than 6 months
-
patients with insufficient medical records.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Hanyang University Guri Hospital | Guri | Korea, Republic of | 11923 | |
| 2 | Hanyang University Seoul Hospital | Seoul | Korea, Republic of | 04763 | |
| 3 | Young-Hyo Lim | Seoul | Korea, Republic of | 04763 |
Sponsors and Collaborators
- Hanyang University Seoul Hospital
- Hanyang University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HYUMC